MAQUET CARDIOVASCULAR RECEIVES FDA 510(K ) CLEARANCE AND CE MARK FOR ITS NEW SENSATION PLUS™INTRA – AORTIC BALLOON CATHETER

MAQUET Cardiovascular has announced that it has received both 510(k) clearance from the U.S. Food & Drug Administration (FDA) and CE mark approval for its new SENSATION PLUS™ 50cc 8 Fr. intra-aortic balloon catheter.

BIOTRONIK Announces Completion of Enrollment in the BIOLUX P-I Clinical Study Investigating Drug-eluting Balloon Therapy for Peripheral Artery Disease

BIOTRONIK has announced the completion of enrollment in the BIOLUX P-I – a clinical study investigating the use of a drug-eluting balloon (DEB) catheter, a promising new approach to treating disease in the more challenging peripheral vascular anatomy.

Abbott Initiates International ABSORB BTK Clinical Trial for Treatment of Below-the-Knee Critical Limb Ischemia

Abbott has announced the initiation of ABSORB BTK, an international clinical trial evaluating the safety and efficacy of the ABSORB™ bioresorbable vascular scaffold (BVS) for the treatment of below-the-knee (BTK) critical limb ischemia.